Share this post on:

Product Name :
RG-6596

Search keywords :
ZN-A-1041

drugId :
null

Target Vo:
Receptor protein-tyrosine kinase erbB-2

Target Vo Short Name :
HER2

Moa_Name:
Receptor protein-tyrosine kinase erbB-2 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Suzhou Zanrong Pharmaceutical Technology Co Ltd

Active Company_Name :
F. Hoffmann-La Roche Ltd

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-CDK1 (Tyr15) Antibody
MSR1 Antibody
His Tag Antibody (HRP) (YA877): His Tag Antibody (HRP) (YA877) is a HRP-conjugated, mouse-derived monoclonal antibody. His Tag Antibody (HRP) (YA877) can be used for: WB expriments in species-independent background.

Share this post on:

Author: Betaine hydrochloride